Literature DB >> 11864912

Insulin-like growth factor-I-induced migration of melanoma cells is mediated by interleukin-8 induction.

Kapaettu Satyamoorthy1, Gang Li, Bhavesh Vaidya, Jiri Kalabis, Meenhard Herlyn.   

Abstract

Successive events of growth factor-induced autocrine and paracrine activation promote tumor growth and metastasis. Insulin-like growth factor-I (IGF-I) stimulates melanoma cells to grow, survive, and migrate. Interleukin-8 (IL-8) is produced by melanoma cells and has been correlated with melanoma metastasis, but the biological functions of this cytokine have not been elucidated. We show here that IGF-I-induced migration of melanoma cells could be inhibited by neutralizing antibody against IL-8. IGF-I overexpression induced IL-8 production in melanoma cells, especially in biologically early melanomas by accelerating its transcription rate via activation of mitogen-activated protein kinase pathway. IGF-I treatment phosphorylated c-Jun and stimulated the binding of AP-1 but not NF-kappaB to the IL-8 promoter. These data identify IL-8 as a new target of IGF-I in melanoma and suggest that some of the biological functions of IGF-I are mediated by IL-8.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11864912

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  16 in total

1.  Interleukin-8 associates with adhesion, migration, invasion and chemosensitivity of human gastric cancer cells.

Authors:  Wen-Xia Kuai; Qiong Wang; Xiao-Zhong Yang; Yao Zhao; Ren Yu; Xiao-Jun Tang
Journal:  World J Gastroenterol       Date:  2012-03-07       Impact factor: 5.742

Review 2.  Cancer-stromal interactions: role in cell survival, metabolism and drug sensitivity.

Authors:  Wan Zhang; Peng Huang
Journal:  Cancer Biol Ther       Date:  2011-01-15       Impact factor: 4.742

3.  Shear stress and shear rate differentially affect the multi-step process of leukocyte-facilitated melanoma adhesion.

Authors:  Shile Liang; Margaret J Slattery; Cheng Dong
Journal:  Exp Cell Res       Date:  2005-09-09       Impact factor: 3.905

4.  Comprehensive analysis of receptor tyrosine kinase activation in human melanomas reveals autocrine signaling through IGF-1R.

Authors:  Kerrington R Molhoek; Amber L Shada; Mark Smolkin; Sudhir Chowbina; Jason Papin; David L Brautigan; Craig L Slingluff
Journal:  Melanoma Res       Date:  2011-08       Impact factor: 3.599

Review 5.  Insulin-like growth factor system and sporadic malignant melanoma.

Authors:  Ettore Capoluongo
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

6.  Gastrin exerts pleiotropic effects on human melanoma cell biology.

Authors:  Véronique Mathieu; Tatjana Mijatovic; Marc van Damme; Robert Kiss
Journal:  Neoplasia       Date:  2005-10       Impact factor: 5.715

7.  Tissue factor-factor VIIa-specific up-regulation of IL-8 expression in MDA-MB-231 cells is mediated by PAR-2 and results in increased cell migration.

Authors:  Gertrud M Hjortoe; Lars C Petersen; Tatjana Albrektsen; Brit B Sorensen; Peder L Norby; Samir K Mandal; Usha R Pendurthi; L Vijaya Mohan Rao
Journal:  Blood       Date:  2004-01-08       Impact factor: 22.113

8.  Cytoskeleton alterations in melanoma: aberrant expression of cortactin, an actin-binding adapter protein, correlates with melanocytic tumor progression.

Authors:  Xu-Zhi Xu; Marileila Varella Garcia; Tian-yu Li; Li-Yan Khor; R Sujatha Gajapathy; Cindy Spittle; Scott Weed; Stuart R Lessin; Hong Wu
Journal:  Mod Pathol       Date:  2009-11-06       Impact factor: 7.842

9.  Expression of CXCR1 and CXCR2 receptors in malignant melanoma with different metastatic potential and their role in interleukin-8 (CXCL-8)-mediated modulation of metastatic phenotype.

Authors:  Michelle L Varney; Aihua Li; Bhavana J Dave; Corazan D Bucana; Sonny L Johansson; Rakesh K Singh
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

10.  The insulin-like growth factor system and its receptors: A potential novel anticancer target.

Authors:  Colin R Lindsay; Tr Jeffry Evans
Journal:  Biologics       Date:  2008-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.